Annual EBIT
-$16.38 M
-$1.47 M-9.84%
December 31, 2023
Summary
- As of February 7, 2025, INDP annual earnings before interest & taxes is -$16.38 million, with the most recent change of -$1.47 million (-9.84%) on December 31, 2023.
- During the last 3 years, INDP annual EBIT has fallen by -$12.78 million (-355.05%).
- INDP annual EBIT is now -355.05% below its all-time high of -$3.60 million, reached on December 31, 2020.
Performance
INDP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.14 M
+$966.80 K+23.53%
September 1, 2024
Summary
- As of February 7, 2025, INDP quarterly earnings before interest & taxes is -$3.14 million, with the most recent change of +$966.80 thousand (+23.53%) on September 1, 2024.
- Over the past year, INDP quarterly EBIT has increased by +$966.80 thousand (+23.53%).
- INDP quarterly EBIT is now -494.42% below its all-time high of -$528.60 thousand, reached on June 30, 2021.
Performance
INDP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$15.37 M
+$1.11 M+6.71%
September 1, 2024
Summary
- As of February 7, 2025, INDP TTM earnings before interest & taxes is -$15.37 million, with the most recent change of +$1.11 million (+6.71%) on September 1, 2024.
- Over the past year, INDP TTM EBIT has increased by +$1.11 million (+6.71%).
- INDP TTM EBIT is now -429.22% below its all-time high of -$2.90 million, reached on June 30, 2020.
Performance
INDP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
INDP EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.8% | +23.5% | +6.7% |
| 3 y3 years | -355.1% | +10.1% | +1.4% |
| 5 y5 years | -355.1% | +10.1% | +1.4% |
INDP EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -111.9% | at low | at high | +29.5% | -98.9% | +6.7% |
| 5 y | 5-year | -355.1% | at low | -494.4% | +29.5% | -429.2% | +6.7% |
| alltime | all time | -355.1% | at low | -494.4% | +29.5% | -429.2% | +6.7% |
Indaptus Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.14 M(-23.5%) | -$15.37 M(-6.7%) |
| Jun 2024 | - | -$4.11 M(+4.2%) | -$16.48 M(+3.9%) |
| Mar 2024 | - | -$3.94 M(-5.7%) | -$15.87 M(-3.1%) |
| Dec 2023 | -$16.38 M(+9.8%) | -$4.18 M(-1.6%) | -$16.38 M(+0.6%) |
| Sep 2023 | - | -$4.25 M(+21.5%) | -$16.29 M(+4.5%) |
| Jun 2023 | - | -$3.50 M(-21.5%) | -$15.59 M(-2.3%) |
| Mar 2023 | - | -$4.46 M(+9.0%) | -$15.96 M(+7.1%) |
| Dec 2022 | -$14.91 M | -$4.09 M(+15.0%) | -$14.91 M(+6.2%) |
| Sep 2022 | - | -$3.55 M(-8.2%) | -$14.04 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$3.87 M(+13.7%) | -$13.86 M(+31.8%) |
| Mar 2022 | - | -$3.40 M(+5.7%) | -$10.52 M(+36.1%) |
| Dec 2021 | -$7.73 M(+114.7%) | -$3.22 M(-4.4%) | -$7.73 M(+46.4%) |
| Sep 2021 | - | -$3.37 M(+537.2%) | -$5.28 M(+52.7%) |
| Jun 2021 | - | -$528.60 K(-13.9%) | -$3.46 M(-40.7%) |
| Mar 2021 | - | -$614.00 K(-20.1%) | -$5.83 M(+11.8%) |
| Dec 2020 | -$3.60 M | - | - |
| Dec 2020 | - | -$768.60 K(-50.3%) | -$5.22 M(+17.3%) |
| Sep 2020 | - | -$1.55 M(-46.8%) | -$4.45 M(+53.2%) |
| Jun 2020 | - | -$2.90 M | -$2.90 M |
FAQ
- What is Indaptus Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Indaptus Therapeutics?
- What is Indaptus Therapeutics annual EBIT year-on-year change?
- What is Indaptus Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Indaptus Therapeutics?
- What is Indaptus Therapeutics quarterly EBIT year-on-year change?
- What is Indaptus Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Indaptus Therapeutics?
- What is Indaptus Therapeutics TTM EBIT year-on-year change?
What is Indaptus Therapeutics annual earnings before interest & taxes?
The current annual EBIT of INDP is -$16.38 M
What is the all time high annual EBIT for Indaptus Therapeutics?
Indaptus Therapeutics all-time high annual earnings before interest & taxes is -$3.60 M
What is Indaptus Therapeutics annual EBIT year-on-year change?
Over the past year, INDP annual earnings before interest & taxes has changed by -$1.47 M (-9.84%)
What is Indaptus Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of INDP is -$3.14 M
What is the all time high quarterly EBIT for Indaptus Therapeutics?
Indaptus Therapeutics all-time high quarterly earnings before interest & taxes is -$528.60 K
What is Indaptus Therapeutics quarterly EBIT year-on-year change?
Over the past year, INDP quarterly earnings before interest & taxes has changed by +$966.80 K (+23.53%)
What is Indaptus Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of INDP is -$15.37 M
What is the all time high TTM EBIT for Indaptus Therapeutics?
Indaptus Therapeutics all-time high TTM earnings before interest & taxes is -$2.90 M
What is Indaptus Therapeutics TTM EBIT year-on-year change?
Over the past year, INDP TTM earnings before interest & taxes has changed by +$1.11 M (+6.71%)